551. Effector functions of Th17 cells are regulated by IL-35 and TGF-β in visceral leishmaniasis.
- Author
-
Asad M, Sabur A, Kamran M, Shadab M, Das S, and Ali N
- Subjects
- Animals, CD4-Positive T-Lymphocytes immunology, CD4-Positive T-Lymphocytes parasitology, Cells, Cultured, Interleukin-2 Receptor alpha Subunit immunology, Leishmania donovani parasitology, Leishmaniasis, Visceral parasitology, Mice, Mice, Inbred BALB C, Th17 Cells parasitology, Interleukins immunology, Leishmaniasis, Visceral immunology, Th17 Cells immunology, Transforming Growth Factor beta immunology
- Abstract
Visceral leishmaniasis (VL) is a debilitating human pathogenesis in which the body's immune functions are severely compromised. Various subsets of T cells, including Th17 cells are important regulators of immune responses observed in various pathologies. The role of Th17 cells and its correlation with immuno-regulatory cytokines are however not well understood in human VL. Herein we studied how IL-17 is associated with the progression of Leishmania donovani infection using murine model of VL. We found induction of a strong IL-17 response at the early phase of infection which progressively reduced to basal level during chronic VL. The mechanistic study of this behavior was found to be linked with the role of regulatory T cells (CD4
+ CD25+ T cells) that suppresses the proliferation of the Th17 cell population. Moreover, TGF-β and IL-35 derived from CD4+ CD25+ T cells are the key mediators for the downregulation of IL-17 during chronic VL. Thus, this study points to an antagonistic effect of Tregs and Th17 cells that can be used for designing better therapeutic and preventive strategies against leishmaniasis., (© 2021 Federation of American Societies for Experimental Biology.)- Published
- 2021
- Full Text
- View/download PDF